Posted on 19th January 2014
Choroideremia affects about 1 in 50,000 people who see their eye sight deteriorating as the light-detecting cells in their eyes die, usually becoming completely blind during their mid-life – a disease not dissimilar to the more widely known retinitis pigmentosa. There has been lots of research in this area but this is the first real world example of success.
Whilst the long-term effects are still unknown, the fact that the trial has had such early successes is a huge step forward and will give real hope to those suffering from various genetic eye diseases.
And it doesn’t stop there. There are many diseases with genetic components that affect eyesight, such as glaucoma which a number of my patients suffer from, and I am hopeful that the same principle could be used to treat a raft of similar diseases in the future.
What is especially heart-warming, is that the research was funded by the Tommy Salisbury Choroideremia Fund set up by the parents of Tommy, a 13-year-old boy from Kent who was diagnosed with the disease eight years ago. Wouldn’t it be great if he reaped the rewards of the research?
Read more about it here
18th January 2021
We are saddened to inform you that at the end of last year we lost our founding partner, Murray McGrath, who many of you will have been treated by over the years. Cameron Optometry started out as W M ...
Read more07th January 2021
This page will have our latest information on the care we can provide during the COVID-19 pandemic. You can also find information on our Facebook page. LATEST UPDATE Thursday, 7 January, 2021 We are...
Read more16th December 2020
We are delighted to let you know that we have a new optometrist joining the practice in January. Alexandra Young is incredibly highly regarded and we are excited to welcome her to the team. In addi...
Read more16th November 2020
Vision plays a vital role in driving, and as a driver it’s important that you ensure you have the best vision possible. To mark Road Safety Week, taking place from 16-22 November, The College of Opt...
Read more